Stock info Dexcom Inc | Filter  Basic-Info

Dexcom Inc

The core activities of Dexcom Inc are in the health care eq. & services sector. Between 2006 and 2016 the global health care companies gained around 102 percent. Measured since 2011 the sector is 64 percent higher and over the past 12 months (December 2015-2016) there is a plus of 102 percent.

The past year was a good year for Dexcom Inc investors

The stock lost over the past 12 months at around 23 percent. The period between August 2011 and August 2016 was a good period for the investors. The stock rose around 689 percent. Dexcom Inc's revenues between 2011 and 2015 were very fluctuating and moved between 99,9 million dollars and 402 million dollars. During 2011 and 2015 Dexcom Inc's net results were very volatile and fluctuated between -44,75 million dollars and -57,6 million dollars.

The American company didn't pay out any dividends (in the past 5 years). Over the past 5 years the company raised it's dividends each year. So because of the yearly raised dividends per share Dexcom Inc is a kind of dividend aristocrat.

Dexcom Inc' balance mostly consists of equity

At the end of 2015 the health care company's balance sheet was worth 292 million dollars. Of the total balance sheet 70,8 million dollars (24,25 percent) was financed by debt. Last year the health care company's price/earnings-ratio (PE) was around -76. So the investors valued the stock at -76 times 2015' earnings per share. Based on the classical stock valuation theories the American stock can be seen as a growth stock.

At the end of 2015 the health care company's market size (her number of outstanding share times the stock price) equaled around 6,37 billion dollars. At the end of 2015 the American company had around 79,8 million stocks listed.

All Dexcom Inc's financial reports are available here. More information about Dexcom Inc can be found it's website. .